Research programme: hygromycin A analogues - PfizerAlternative Names: CE-129941; CE-156811
Latest Information Update: 06 Aug 2008
At a glance
- Originator Pfizer
- Mechanism of Action Peptidyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 06 Aug 2008 Preclinical development is ongoing in USA